- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Contraception
- Meeting Date: May 2025
- Public Summary Document (PSD) May 2025 PBAC Meeting - (PDF)
- Public Summary Document (PSD) May 2025 PBAC Meeting - (Word)
Etonogestrel with Ethinylestradiol – May 2025
Etonogestrel with Ethinylestradiol: Vaginal ring containing etonogestrel 11.7 mg with ethinylestradiol 2.7 mg; NuvaRing®
Last updated
9 May 2025